You have full text access to this OnlineOpen article
Factor V Leiden: the venous thrombotic risk in thrombophilic families
Article first published online: 24 DEC 2001
DOI: 10.1046/j.1365-2141.2000.02236.x
Additional Information
How to Cite
Lensen, R., Rosendaal, F., Vandenbroucke And, J. and Bertina, R. (2000), Factor V Leiden: the venous thrombotic risk in thrombophilic families. British Journal of Haematology, 110: 939–945. doi: 10.1046/j.1365-2141.2000.02236.x
Publication History
- Issue published online: 24 DEC 2001
- Article first published online: 24 DEC 2001
- Received 30 December 1999; accepted for publication 4 May 2000
References
- & (1994) Familial venous thrombophilia. In: Haemostasis and Thrombosis (eds A.L.Bloom, C.D.Forbes, D.P.Thomas et al), pp. 1349 1360. Churchill-Livingstone, New York.
- , , , , , (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet, 341, 134 138.
- , , , , (1995) Survival in families with hereditary protein C deficiency, 1820–1993. British Medical Journal, 311, 910 913.
- , , , , , , , (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64 67.
- , , , , (1994) The family history and inherited thrombophilia. British Journal of Haematology, 87, 348 352.Direct Link:
- (1995) Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood, 85, 607 614.
- , , (1990) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004 1008.
- & (1994) Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thrombosis and Haemostasis, 72, 880 886.
- , , , , , (1994) Activated protein C resistance causes by Arg 506 Gln mutation in factor Va. Lancet, 343, 1361 1132.
- , , , (1993) Anticoagulant protein C pathway defective in majority of thrombophilia patients. Blood, 82, 1989 1993.
- , , , (1997) Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). Blood, 89, 1963 1967.
- , , (1986) Epidemiology and pathogenesis of venous thrombosis. Journal of the American College of Cardiology, 8, 104B 113B.
- , , , , , (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 1503 1506.
- , , , , , , , , , , , (1996) Inherited thrombophilia: part 1 & 2. Thrombosis and Haemostasis, 76, 651 662&824 834.
- , , , , , , , (1996) Apparent different thrombotic tendency in patients with Factor V Leiden and Protein C deficiency due to selection of patients. Blood, 88, 4205 4208.
- , , , , (2000) Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thrombosis and Haemostasis, 83, 817 821 .
- , , , , (1996) Mutant factor V (Arg506Gln) in healthy centenarians. Lancet, 347, 1044.
- , , , , , , , (1998) The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Annals of Internal Medicine, 128, 15 20.
- & (1993) Hypercoagulable states. Annals of Internal Medicine, 119, 819 827.
- National Medical Registration of the Foundation Information Centre for Health Care (1996) SIG, Utrecht, the Netherlands.
- , , , (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine, 232, 155 160.Direct Link:
- , , , (1996) A common genetic variation in the 3′- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698 3703.
- , , (1998) Long-term outcomes after deep vein thrombosis of the lower extremities. Vascular Medicine, 3, 57 60.
- , , (1995) World distribution of factor V Leiden. Lancet, 346, 1133 1134.
- , , , , , (1995) Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation, 92, 2800 2802.
- (1997) Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thrombosis and Haemostais, 78 (suppl.), 1 6.
- , , , , , , , (1991) Mortality in hereditary antithrombin-III deficiency – 1830–1989. Lancet, 337, 260 262.
- , , , (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 55, 1504 1508.
- , , , , , , , , (1997) The risk of recurrent venous thromboembolism in patients with an Arg506Gln mutation in the gene for factor V. New England Journal of Medicine, 336, 399 403.
- , , , , , , , , , , , (1999) Incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis and Haemostasis, 81, 198 202.
- & (1994) Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine, 330, 517 522.
- , , , , , , , (1994) Hereditary antithrombin deficiency. Heterogeneity of the molecular basis and mortality in Dutch families. Blood, 84, 4209 4213.
- , , , , , , , (1994) Association of idiopathic venous thromboembolism with single point mutation at Arg506 of factor V. Lancet, 343, 1535 1536.
- , , , , , , , , (1997) A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood, 89, 397 402.
- , , , (1994) Identification of the same factor V gene mutation in 47 of 50 thrombosis-prone families with inherited resistance to activated protein C. Journal of Clinical Investigation, 94, 2521 2524.

1365-2141/asset/olbannerleft.gif?v=1&s=2237887a0dba115836e329b1c5824f93749b814b)
1365-2141/asset/olbannerright.gif?v=1&s=01b5795d608a5571b530fcd8eb300f01b48de3b2)
1365-2141/asset/cover.gif?v=1&s=340532f3ee73ba9171e38abd4d7f6a926d117661)